Respiratory Motion

Respiratory Motion, a commercial-stage medical device company founded in 2010, is dedicated to providing early warnings of respiratory collapse across diverse patient populations and medical environments. The company's slogan "Providing early warning of respiratory collapse across diverse patient populations and medical environments" reflects its core mission to evaluate respiratory function and offer crucial early warnings. Specializing in the Biotechnology, Health Care, and Medical Devices industries, Respiratory Motion focuses on medical devices, clinical evaluation and testing, manufacturing, and respiratory monitoring. The company's latest milestone includes securing a substantial $17.70M Series D investment on 01 May 2019, signaling confidence and support from the investment community. While the specific details of the investors were not disclosed, this significant investment represents a vote of confidence in Respiratory Motion's innovative approach and potentially game-changing solutions in the critical area of respiratory care.